6-chloro-2-(3-(dimethylamino)pyrrolidin-1-yl)-N-(((1S,3R)-1-hydroxy-3-methylcyclohexyl)methyl)quinoline-5-carboxamide

ID: ALA4449293

Chembl Id: CHEMBL4449293

PubChem CID: 155520870

Max Phase: Preclinical

Molecular Formula: C24H33ClN4O2

Molecular Weight: 445.01

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H]1CCC[C@@](O)(CNC(=O)c2c(Cl)ccc3nc(N4CCC(N(C)C)C4)ccc23)C1

Standard InChI:  InChI=1S/C24H33ClN4O2/c1-16-5-4-11-24(31,13-16)15-26-23(30)22-18-6-9-21(27-20(18)8-7-19(22)25)29-12-10-17(14-29)28(2)3/h6-9,16-17,31H,4-5,10-15H2,1-3H3,(H,26,30)/t16-,17?,24+/m1/s1

Standard InChI Key:  DXYPZGNOLQPKSH-PQXMGZSVSA-N

Alternative Forms

  1. Parent:

    ALA4449293

    ---

Associated Targets(Human)

P2RX7 Tchem P2X purinoceptor 7 (5534 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2rx7 P2X purinoceptor 7 (1132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2rx7 P2X purinoceptor 7 (169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.01Molecular Weight (Monoisotopic): 444.2292AlogP: 3.70#Rotatable Bonds: 5
Polar Surface Area: 68.70Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.85CX Basic pKa: 9.09CX LogP: 3.80CX LogD: 2.11
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.74Np Likeness Score: -1.11

References

1. Xiao Y, Karra S, Goutopoulos A, Morse NT, Zhang S, Dhanabal M, Tian H, Seenisamy J, Jayadevan J, Caldwell R, Potnick J, Bleich M, Chekler E, Sherer B, Sriraman V..  (2019)  Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonists.,  29  (13): [PMID:31031055] [10.1016/j.bmcl.2019.04.033]

Source